Praxis precision medicines to present at stifel's 3rd annual cns day

Cambridge, mass., march 24, 2021 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (cns) characterized by neuronal imbalance, today announced that management will participate in a fireside chat at stifel's 3rd annual cns day on wednesday, march 31, 2021 at 8:30 a.m. et.
PRAX Ratings Summary
PRAX Quant Ranking